[PDF][PDF] Inflammatory theory of depression
P Gałecki, M Talarowska - Psychiatr Pol, 2018 - researchgate.net
Brain diseases are one of the most socially and economically burdening diseases in
Europe. Among all brain diseases, more than 60% of social and economic costs are …
Europe. Among all brain diseases, more than 60% of social and economic costs are …
[HTML][HTML] The role of lipid biomarkers in major depression
In the UK, the lifetime-documented prevalence of major depressive disorder (MDD) is
currently 10%. Despite its increasing prevalence and devastating impact on quality of life …
currently 10%. Despite its increasing prevalence and devastating impact on quality of life …
[HTML][HTML] Treating major depression with yoga: A prospective, randomized, controlled pilot trial
S Prathikanti, R Rivera, A Cochran, JG Tungol… - Plos one, 2017 - journals.plos.org
Background Conventional pharmacotherapies and psychotherapies for major depression
are associated with limited adherence to care and relatively low remission rates. Yoga may …
are associated with limited adherence to care and relatively low remission rates. Yoga may …
[HTML][HTML] Prevalence and impact of treatment-resistant depression in Latin America: a prospective, observational study
B Soares, G Kanevsky, CT Teng, R Pérez-Esparza… - Psychiatric …, 2021 - Springer
Approximately one-third of patients with major depressive disorder (MDD) have treatment-
resistant depression (TRD). The TRAL study will evaluate the prevalence and impact of TRD …
resistant depression (TRD). The TRAL study will evaluate the prevalence and impact of TRD …
[HTML][HTML] Investigational drugs for the treatment of depression (part 1): monoaminergic, orexinergic, GABA-ergic, and anti-inflammatory agents
O Vasiliu - Frontiers in Pharmacology, 2022 - frontiersin.org
Therapeutic management of depression has currently important limitations, and its low
efficacy is reflected in high rates of non-response even after multiple trials of …
efficacy is reflected in high rates of non-response even after multiple trials of …
Efficacy and safety of seltorexant as adjunctive therapy in major depressive disorder: a phase 2b, randomized, placebo-controlled, adaptive dose-finding study
A Savitz, E Wajs, Y Zhang, H Xu… - International Journal …, 2021 - academic.oup.com
Background Seltorexant, a selective antagonist of human orexin-2 receptors, demonstrated
antidepressant effects in a previous exploratory study in patients with major depressive …
antidepressant effects in a previous exploratory study in patients with major depressive …
Precision clinical trials: a framework for getting to precision medicine for neurobehavioural disorders
The goal of precision medicine (individually tailored treatments) is not being achieved for
neurobehavioural conditions such as psychiatric disorders. Traditional randomized clinical …
neurobehavioural conditions such as psychiatric disorders. Traditional randomized clinical …
Prospective service use and health care costs of Medicaid beneficiaries with treatment-resistant depression
M Olfson, TB Amos, C Benson, J McRae… - Journal of Managed Care …, 2018 - jmcp.org
BACKGROUND: Although the clinical and health economic characteristics of commercially
insured adults with treatment-resistant depression (TRD) have been well characterized, little …
insured adults with treatment-resistant depression (TRD) have been well characterized, little …
[HTML][HTML] Investigation of early and lifetime clinical features and comorbidities for the risk of developing treatment-resistant depression in a 13-year nationwide cohort …
SS Huang, HH Chen, J Wang, WJ Chen, HC Chen… - BMC psychiatry, 2020 - Springer
Background To investigate the risk of treatment-resistant depression (TRD) in patients with
depression by examining their clinical features, early prescription patterns, and early and …
depression by examining their clinical features, early prescription patterns, and early and …
[HTML][HTML] Delayed effect of bifrontal transcranial direct current stimulation in patients with treatment-resistant depression: a pilot study
MS Li, XD Du, HC Chu, YY Liao, W Pan, Z Li… - BMC psychiatry, 2019 - Springer
Background Transcranial direct current stimulation (tDCS) is a non-invasive brain
stimulation technique, which has yielded promising results in treating major depressive …
stimulation technique, which has yielded promising results in treating major depressive …